Oryzon Genomics S.A. (ORYZF)

USD 1.79

(0.0%)

Long Term Debt Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual long term debt in 2023 was 3.45 Million EUR , down -51.13% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly long term debt in 2024 Q3 was - EUR , down -100.0% from previous quarter.
  • Oryzon Genomics S.A. reported annual long term debt of 7.06 Million EUR in 2022, down -31.76% from previous year.
  • Oryzon Genomics S.A. reported annual long term debt of 10.34 Million EUR in 2021, up 95.15% from previous year.
  • Oryzon Genomics S.A. reported quarterly long term debt of - EUR for 2024 Q3, down -100.0% from previous quarter.
  • Oryzon Genomics S.A. reported quarterly long term debt of 3.19 Million EUR for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Oryzon Genomics S.A. (2023 - 2014)

Historical Annual Long Term Debt of Oryzon Genomics S.A. (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 3.45 Million EUR -51.13%
2022 7.06 Million EUR -31.76%
2021 10.34 Million EUR 95.15%
2020 5.3 Million EUR 40.24%
2019 3.78 Million EUR -48.88%
2018 7.39 Million EUR -43.58%
2017 13.1 Million EUR -12.23%
2016 14.93 Million EUR 386.48%
2015 3.06 Million EUR 4.69%
2014 2.93 Million EUR 0.0%

Peer Long Term Debt Comparison of Oryzon Genomics S.A.

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 83.497%
Evofem Biosciences, Inc. 8000.00 USD -43032.688%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -96.563%
Mesoblast Limited 100.29 Million USD 96.56%
Propanc Biopharma, Inc. 58.64 Thousand USD -5784.204%
Genus plc 228.2 Million USD 98.488%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD -417.234%
ContraFect Corporation 2.21 Million USD -56.136%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -145.957%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 36.412%
MultiCell Technologies, Inc. 36.43 USD -9471805.023%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 93.795%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD -55.014%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -180.912%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 97.923%
Oncotelic Therapeutics, Inc. 1.89 Million USD -81.758%
Skye Bioscience, Inc. 171.23 Thousand USD -1915.193%
Therapeutic Solutions International, Inc. 5512.00 USD -62501.869%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 87.406%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -971.62%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.969%
Halberd Corporation 150 Thousand USD -2200.41%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD -1050.205%
Nuo Therapeutics, Inc. 164.2 Thousand USD -2001.407%
argenx SE 15.35 Million USD 77.526%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 83.012%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -77337.5%
Genscript Biotech Corporation 287.12 Million USD 98.798%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -2632.035%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -1404.906%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -522.192%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -13539.334%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 58.245%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -1199.006%
ONE Bio Corp. 592.19 Thousand USD -482.679%
Reve Technologies, Inc. 1064.00 USD -324205.921%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -2206.345%
Regen BioPharma, Inc. 149.61 Thousand USD -2206.345%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -1402.286%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -2347.245%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -4213.269%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 55.874%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -835.002%
International Stem Cell Corporation 445 Thousand USD -675.419%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 57.661%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -655.058%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -197.211%
PureTech Health plc 18.25 Million USD 81.093%
Coeptis Therapeutics, Inc. 150 Thousand USD -2200.41%
IXICO plc 275 Thousand USD -1154.769%
IntelGenx Technologies Corp. 11.83 Million USD 70.854%
Gelesis Holdings, Inc. 26.3 Million USD 86.884%
CSL Limited 11.23 Billion USD 99.969%
Cellectis S.A. 36.21 Million USD 90.471%